Reduced prostaglandin F2α release from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study

Reduced prostaglandin F2α release from blood mononuclear leukocytes after oral supplementation of ω3 fatty acids: the OmegAD study

Omega-3 fatty acids, e.g., dokosahexaenoic acid (DHA) and eikosapentaenoic acid (EPA), ameliorate inflammatory reactions by various mechanisms, but the role of prostaglandins remains unclear. Our aim was to determine if dietary supplementation with a DHA-rich fish oil influenced the release of PGF2α...

Full description

Bibliographic Details
Main Authors: Inger Vedin, Tommy Cederholm, Yvonne Freund-Levi, Hans Basun, Erik Hjorth, Gerd Faxén Irving, Maria Eriksdotter-Jönhagen, Marianne Schultzberg, Lars-Olof Wahlund, Jan Palmblad
Format: Article
Language:English
Published: Elsevier 2010-05-01
Series:Journal of Lipid Research
Subjects:
DHA
EPA
LPS
Omega-3 fatty acid
PBMC
PGF
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520410739

Internet

http://www.sciencedirect.com/science/article/pii/S0022227520410739

Similar Items